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Abstract 
Neonatal Diarrheal Disease is responsible for significant economic losses to the livestock industries in 
Canada and around the world. Microbes responsible are diverse and include Escherichia coli, Salmonella, 
Rotavirus, Coronavirus and Cryptosporidia. While the use of antibiotics as a treatment for bacterial 
infections and as a prophylactic additive in feed has dramatically improved cattle production in recent 
decades, the increasing pressure to reduce or eliminate use of antibiotics in animals has caused the 
livestock industry to seek appropriate alternatives. Antimicrobial/Host Defense Peptides are natural 
compounds present on skin and in secretions in plants and animals that are microbicidal for bacteria, 
viruses, and parasites and they stimulate the immune system to combat infectious diseases. Our objective 
is to establish orally-obtained Host Defense Peptides (HDPs) as an alternative to antibiotics to protect 
against Neonatal Diarrheal Disease in calves. We devised a method to allow the cow udder to act as a 
factory to produce HDPs so that suckling calves will receive a continuous oral dose of HDPs over several 
weeks to protect them against neonatal diarrhea. We will use Adenovirus to deliver a gene coding for 
several HDPs in-frame into mammary epithelial cells. The epithelial cells will secrete the HDP protein 
into milk to be consumed by the suckling calves and trypsin in the calf gut will release the HDPs through 
cleavage. Thus, the novelty of this research lies not only in the proposed alternative to antibiotics to 
protect neonates against disease, but in the method by which we introduce the peptides to the suckling 
offspring.  
 
© 2012 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the 5th vaccine 
conference organizing committee. 
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1. Introduction 
Neonatal Diarrheal Disease is one of the leading causes of morbidity and mortality in dairy and beef 
calves and improved prevention and treatment methods would be of significant economic benefit to the 
cattle industry. The use of antibiotics as a treatment for bacterial infections and as a prophylactic additive 
in feed has dramatically improved cattle production in the last century, however, the rise of antibiotic-
resistant bacteria and pressure to reduce or eliminate use of antibiotics has collectively driven livestock 
industries to seek appropriate alternatives.  
 
Host Defense Peptides (HDPs; also known as antimicrobial peptides or innate defense regulators) are 
natural compounds present on skin and in secretions such as tears, saliva and milk in cattle and other 
animals. HDPs are naturally anti-bacterial, anti-viral and anti-parasitic, and they can also stimulate the 
immune system to combat infectious diseases [1-3]. Unlike antibiotics, HDPs are not disease-specific and 
can at once potentially protect against multiple bacterial, viral and parasitic challenges. In this report, we 
selected four HDPs (Indolicidin (Indol), Lactoferricin (LFn), Bovine Myeloid Antimicrobial Peptide-27 
(BMAP-27), and Protegrin-1 (PG-1)) which have individually been shown to possess anti-microbial, anti-
inflammatory or immunomodulatory activities [1, 4-7]. We evaluated their synergistic effects in induction 
of IL-8 expression, and indicator of innate immune activation, and their anti-microbial activity.  
 
Supplementation of HDPs such as Lactoferrin into diet has been shown to protect calves against 
bacterial diseases suggesting that HDPs may be an effective replacement for antibiotics in feed [8]. 
However, adding synthetic peptides directly to feed or water as a prophylactic treatment and/or to treat 
disease is cost-prohibitive. To circumvent these costs, we devised a novel HDP delivery system: We 
intend to manipulate the cow's mammary glands to secrete significant quantities of select HDPs into milk 
using adenovirus gene delivery system. Through consumption of HDP-enriched milk, the calf will be 
supplemented with HDPs, which can then act directly as antimicrobial agents as well as influence the calf 
gastrointestinal immune system to protect against Neonatal Diarrheal Disease.  
 
2. Materials and Methods 
2.1. Cell lines and culture conditions  
The bovine mammary epithelial cells (MAC-T cells) were obtained from the American Type 
Culture Collection (ATCC CRL-10274; Rockville, MD, USA) and cultured as indicated in [9]. 
2.2. Peptide synthesis 
The following peptides were purchased from ChemPep (Wellington, Fl, USA): Indol (N-
ILPWKWPWWPWRRG-C; GenBank: NM_174827), BMAP-27 (N-GRFKRFRKKFKKLFKKLSPVI-
PLLHLG-C; GenBank: NM_174832), and PG-1(N-RGGRLCYCRRRFCVCVGR-C; GenBank: 
NM_001123149).   
 
LFn (N-IEGRFKCRRWQWRMKKLGAPSITCVRRAF-C; GenBank: AAQ98614.1) was 
synthesized in-house on a PIONEER™ solid-phase peptide synthesizer (Applied Biosystems Life 
Sciences, Foster City, CA, USA) using Fmoc (9-fluorenylmethoxy carbonyl) chemistry. Peptide chains 
were synthesized from the carboxyl  terminus to the amino terminus onto [5-(4-Fmoc-aminomethyl-3,5-
dimethyloxyphenoxy) valeric acid]-polyethylene glycol-polystyrene (PAL-PEG-PS) resin (OVA (Sigma-
Aldrich Canada Ltd, Oakville, ON, Canada). Fmoc-protecting groups at the amino terminus were 
deprotected with piperidine. The peptides were cleaved from the resin with concurrent deprotection of the 
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side chain-protecting groups by treating the resin-bound peptide with trifluoroacetic acid (TFA) (Sigma) 
(9.3 parts) in the presence of scavengers (anisole-ethyl-methyl sulfide-1,2-ethanedithiol [3:3:1]), for 4 h. 
The crude peptides were filtered from the resin, and the TFA was evaporated. Diethyl ether (Sigma) was 
added to the residues to precipitate the crude peptide. The peptides were isolated and purified by high-
performance liquid chromatography (HPLC) on VYDAC® protein C4 columns (1.0 by 25 cm) eluting 
with a linear gradient of 10% buffer A (H2O–0.1% TFA)–90% buffer B (acetonitrile–H2O [90/10]–0.01% 
TFA) for 40 min at a flow rate of 3 mL/min. Fractions of greater than 95% purity were analyzed on a 
4800 Matrix Assisted Laser Desorption Ionisation (MALDI) Time of Flight (TOF)/TOF Analyzer Mass 
Spectrometer (Applied Biosystems Life Sciences, Carlsbad, CA, USA), at the National Research Council, 
Saskatoon, Saskatchewan, Canada. HDPs were diluted in sterile, pyrogen-free saline (Sigma). 
 
2.3 Anti-microbial assay 
Enterotoxigenic E. coli  strain B44 (O9:K30;K99:H-) [10] was grown in minimal media (Vogel Bonner 
media; VB [11]) or Brain-Heart Infusion (BHI; Fisher) as indicated at 37o C in a shaking incubator until it 
reached log phase. A concentration of 105 cfu/ml was plated into a round-bottom, Nunc 96-well plate 
(Fisher Scientific) then incubated with the peptide cocktail (each peptide was included at 50 µg/ml, 12.5 
µg/ml, 6.25 µg/ml, 1.5 µg/ml or 0 µg/ml (media alone)) for 18 hrs at 37o C . The E. coli was then plated 
onto MacConkey agar plates (Fisher) the next day. Results were recorded as follows: (-) =  no growth, (+) 
= low growth (very few colonies), (++) = medium growth, (+++) = heavy growth, (++++) = (very heavy 
growth).  
2.4. Cellular viability assay 
A Trypan blue exclusion assay was used to assess the cytotoxicity of the peptides on MAC-T cells. 
Cells were cultured in the presence of the peptides for 24 h before incubation with 0.025 % Trypan Blue 
(Invitrogen, Burlington, ON, CAN). The number of viable (clear) and dead (blue) cells were assessed by 
flow cytometry and presented in Table 1 as a percentage of viable (clear) cells in the presence of media or 
increasing concentration of HDPs.  
2.5.  IL-8 protein expression 
IL-8 expression was quantified using DuoSet® ELISA kit (R&D Systems, Minneapolis, MN, USA) 
according to the manufacturer’s instructions. 
 
2.6.  Gene design, cloning and replication-defective adenovirus construction and amplification. 
Using their proprietary OptimumGeneTM technology, we purchased a gene designed to code for the 
active regions of Indol, Lactoferrin, BMAP-27, PG-1 and FLAG ( N-DYKDDDDK-C) from GenScript 
(Piscataway, NJ USA) (Supplementary Fig 1) and the gene (5’Signal-Indol/LFn/BMAP-27/PG-1-FLAG 
3’) was cloned into a CpG-free vector (pCpGfree-mcs Invivogen, San Diego, CA, USA) using BglII and 
NcoI restriction endonuclease sites (New England Biolabs Ltd., Pickering, ON, Canada). The gene was 
designed such that it had minimal CpG oligodeoxynucleotides and was optimized for high expression in 
sheep (i.e. sheep were chosen as our animal model of choice instead of calves due to lower costs).   
 
2.7. Adenovirus-mediated cloning and transduction. 
E1-substituted Ad5 Adenovirus cloning was performed by O.D.260, Inc. as detailed in [12]. 
Recombinant adenovirus vectors were amplified in 293 cells (ATCC; CRL-1573). Cells were cultured in 
DMEM (Life Technologies, Rockville, MD, USA) supplemented with 10% fetal calf serum (FCS) 
(Sigma), 4 mM glutamine, 1% penicillin-streptomycin (Life Technologies), and 4.5 mg glucose/L. CsCl-
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purified virus was dialyzed against GTS buffer (2.5% glycerol, 25 mM NaCl, 20 mM Tris-HCl pH 8.0; 
(Sigma)) and  filtered through a 0.22 µm Millex-GV membrane (Fisher Scientific, Mississauga, ON, 
Canada).  Infectious virus titres were determined using TCID50 assay [13].  
 
2.8. Dot-Blot Analysis. 
The 293 cells were plated in 6 well Nunc plates (Nalgene) for 18 hr prior to transduction with 2 µl 
crude extract of Adenovirus coding for Indol/LFn/BMAP-27/PG-1-FLAG in 2 ml total volume. Seventy-
two hours later, supernatants were collected and frozen at -80 oC. Supernatants were evaporated by 
Speed-Vac to approximately 200 µl volume and 10 % was added to methanol-treated, dried, PVDF 
membrane. Five µg of 293 cellular supernatants which had previously been transfected with bacterial 
plasmid expressing FLAG (a kind gift from McFie and Stone [14]) was also blotted onto the membrane 
and was allowed to dry at room temperature. The blot was blocked with 1 % skim milk in 0.05 %Tween 
20 in Tris-buffered saline (TBST). TBST buffer for 1 hour. Primary rabbit anti-FLAG antibody (1 µg/ml; 
Genscript, Piscataway, NJ, USA) was incubated with the blot at room temperature with gentle shaking for 
2 hr. After washing 3 times with 5 ml of 1% skim milk/TBST, the secondary Alkaline-phosphatase-
conjugated goat-anti-rabbit antibody (KPL, Gaithersburg, MD, USA) was incubated for 1 hour at room 
temperature gentle shaking. Blots were washed 3 times with 1% skim milk in TBST for 5 minutes each 
followed by three washes in TBST. Blots were washed 4 times with ddH2O then 5-bromo-4-chloro-3-
indolyl phosphate/nitroblue tetrazolium (NBT/BCIP) (Sigma) insoluble alkaline substrate solution was 
added as per manufacturer’s instruction. 
 
3. Results and discussion 
Because our ultimate goal is adenovirus-mediated HDP expression into cow milk for consumption 
by the calf, we anticipate that there will be a significant dilution effect in the milk and the large surface 
area of the gut. Therefore, we sought to identify a cocktail of HDPs which are effective at low 
concentrations. We evaluated the microbicidal activity of Indol, LFn, BMAP-27, and PG-1 alone and in 
combination against an E. coli K99 bovine field isolate known to cause Neonatal Diarrheal Disease in 
cattle [10]. Individually and in the majority of combinations, Indol, LFn, BMAP-27, and PG-1 were 
poorly microbicidal at 1.5 µg/ml (Table 1). However, when Indol/LFn/BMAP-27/PG-1-FLAG were 
introduced to the bacteria at 1.5 µg/ml each, the cocktail proved to be strongly anti-microbial. A trypan 
blue exclusion assay determined that even when Indol/LFn/BMAP-27/PG-1 were at 12. 5 µg/ml, they 
were not cytotoxic to MAC-T cells (Table 2). Next, we evaluated the effect that Indol/LFn/BMAP-
27/PG-1 had on IL-8 protein expression, a chemokine known to induce both chemotaxis and activation of 
neutrophils [15, 16] and an indicator or innate immune activation. Although this experiment needs to be 
repeated to establish whether these results are statistically significant, Indol/LFn/BMAP-27/PG-1 (1.5 
µg/ml) prompted a moderate induction of IL-8 expression in MAC-T cells. In the presence of LPS, 
Indol/LFn/BMAP-27/PG-1 showed a strongly synergistic effect with production of > 3,000 pg/ml IL-8 
after 48 hours. Thus, we have chosen to clone Indol/LFn/BMAP-27/PG-1 into adenovirus for further 
analysis.   
 
To circumvent the costs associated with HDP production, we devised a procedure where-in the 
mammary glands of the cow will act to produce the HDPs which will be supplied to the suckling calf 
through the milk. We designed a gene such that Indol’s natural signal peptide sequence was in-frame to 
the active region of Indol which was also in-frame with the active sequences for LFn, BMAP-27, PG-1 
and FLAG. Because there are no commercially available antibodies against Indol, LFn, BMAP-27 or PG-
1, we included the FLAG epitope as part of the gene product. Detection of FLAG using anti-FLAG 
antibodies could be used to infer expression of Indol, LFn, BMAP-27 and PG-1. The gene was designed 
25 Heather L. Wilson et al. /  Procedia in Vaccinology  6 ( 2012 )  21–32 
so that each HDP were separated from each other by four codons coding for Arginine. When translated 
into a protein, the HDPs will be freed from each other through trypsin digestion. This gene was 
synthesized as indicated in Materials and Methods and cloned into a CpG-free expression plasmid. In 
turn, the gene was sub-cloned into a replication defective adenovirus. When 293 cells were transduced 
with the modified adenovirus, we detected FLAG expression through dot-blot analysis suggesting that the 
peptides were also being expressed.  
In future experiments, we intend to evaluate whether adenovirus-derived HDPs, like their synthetic 
counterparts, are strongly anti-microbial and promote IL-8 expression from MAC-T cells when co-
stimulated with LPS. Once satisfied that the adenovirus-derived peptides are functional, we will transduce 
udders directly through the teat canal and then monitor the milk for the HDP/FLAG protein using 
antibodies against FLAG. Once consumed by the calf, the HDP/FLAG protein will travel to the trypsin-
rich gut and, through enzymatic digestion, Indol, LFn, BMAP-27 and PG-1:FLAG will be released. Calf’s 
will be infected with E. coli K99 to establish whether continuous exposure to adenovirus-derived HDPs 
protects them against Neonatal Diarrheal Disease. 
 
4. Conclusions 
In this study, Indol/LFn/BMAP-27/PG-1 were shown to be strongly antimicrobial against E. coli K99 
but not cytotoxic to bovine mammary epithelial cells. The peptide cocktail synergized with LPS to 
promote robust quantities of IL-8 protein from MAC-T cells. Together, these results suggest that 
Indol/LFn/BMAP-27/PG-1 are strongly immunomodulatory and anti-microbial. Our next steps will be to 
establish adenovirus-mediated expression of Indol/LFn/BMAP-27/PG-1 in cow milk, and to determine 
whether it protect calves against Neonatal Diarrheal Disease. 
26   Heather L. Wilson et al. /  Procedia in Vaccinology  6 ( 2012 )  21–32 
 
Table 1. Minimum Inhibitory Concentration (MIC) Assay 
 
Peptide Cocktail Composition* Growth** 
Media,  ++++ 
Indol ++++ 
BMAP-27 ++++ 
LFn ++++ 
PG-1 ++++ 
Indol, LFn ++++ 
Indol, BMAP-27 ++++ 
Indol, PG-1 ++++ 
LFn, BMAP-27 ++++ 
LFn, PG-1 ++++ 
BMAP-27, PG-1 ++++ 
Indol, LFn, PG-1 ++++ 
Indol, BMAP-27, PG-1 ++++ 
Indol, LFn, BMAP-27, PG-1*** - 
* The concentration of each peptide was 1.5 µg/ml. 
** E. coli was grown in BHI media. 
*** E. coli was also grown VB media with similar results 
 
 
 
Table 2. Trypan Blue Viability Assay 
 
Peptide Cocktail 
Composition 
Peptide Conc. 
(µg/ml) 
Percent Viability 
(%)* 
Indol, LF, BMAP-27  
and PG-1          0 
 
  96 
 
     0.75   96 
 
     1.50 100 
 
     3.13   96 
 
     6.25   93 
   12.50   97 
*Cytotoxicity was assessed using MAC-T cells. 
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Fig 1. HDP cocktail-induced IL-8 protein expression. Bovine MAC-T epithelial cells were incubated for 72 hr with 
20 µg/ml LPS, 1.5 µg/ml Indol/LFn/BMAP-27/PG-1 (HDP), LPS + 1.5 µg/ml Indol/LFn/BMAP-27/PG-1 or media 
alone. Il-8 protein production was measured in the supernatants using ELISA analysis. Although preliminary, these 
data indicate that HDP+LPS trigger robust production of IL-8 from mammary epithelial cells (n=1).  
 
 
 
 
Fig 2. Dot-blot hybridization to detect FLAG epitope. Adenovirus coding for the HDP gene of interest was used to 
transduce 293 cells and supernatant was collected after 72 hours. For the positive control, 5 µg of total protein 
obtained from supernatants from 293 cell transfected with bacterial plasmid DNA coding for FLAG, was used. 
Supernatants were blotted onto PVDF membrane and hybridized with anti-FLAG antibody. Adenovirus transduced 
293 cells expressed FLAG and therefore must also produce the HDP active regions. 
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Fig 3: Schematic representation of the transfer of active HDPs to the calf gut via adenovirus-mediated gene 
expression in cow milk. The active portion of Indol/LFn/BMAP-27 and PG-1 were cloned in-frame to an bacterial-
like plasmid which was in turn be introduced to an adenovirus vector. The gene includes a sequence corresponding to 
the Sequence Recognition Particle (Signal) to ensure secretion of the protein outside of the cell and a FLAG tag for 
detection and quantification purposes. The adenovirus will be injected into the mammary tissue through the teat canal 
with the intent that it will  transduce the mammary epithelial cells which will, in turn, generate the HDP protein into 
the milk. Upon consumption by the calf, the HDP protein will travel to the gut where trypsin will cleave the HDP 
protein to release the active peptides. Images were obtained through public domain sites www.clker.com/clipart and 
www.imagefree.org.
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Appendix A: Supplementary Figure. 
 
 
 
Supplementary Figure 1. Nucleotide and predicted amino acid sequence of the synthetic gene construct designed by 
GenScript, Ltd. The nucleotide sequence is numbered on the left and the one-letter code for each amino acid is listed 
below the codon. The BglII and NcoI restriction endonuclease sites flanking the gene are larger font. The Signal 
recognition sequence for Indolicidin is in-frame at the 5’-end of the gene to ensure that the translated sequence is 
targeted for secretion. The amino acid sequences for Indol, BMAP-27, LFn and PG-1 active sites are in bold and 
underlined font. The sequence for the FLAG peptide is within a boxed region. The arginine rich trypsin peptidase 
cleavage sites separating the HDP sequences are in normal font. The stop codons are marked with an asterisk. 
 
